Abstract：
:The mechanism whereby cationic lipids destabilize cell membranes to facilitate the intracellular delivery of macromolecules such as plasmid DNA or antisense oligonucleotides is not well understood. Here, we show that cationic lipids can destabilize lipid bilayers by promoting the formation of nonbilayer lipid structures. In particular, we show that mixtures of cationic lipids and anionic phospholipids preferentially adopt the inverted hexagonal (H(II)) phase. Further, the presence of 'helper' lipids such as dioleoylphosphatidylethanolamine or cholesterol, lipids that enhance cationic lipid-mediated transfection of cells also facilitate the formation of the H(II)phase. It is suggested that the ability of cationic lipids to promote nonbilayer structures in combination with anionic phospholipids leads to disruption of the endosomal membrane following uptake of nucleic acid-cationic lipid complexes into cells, thus facilitating cytoplasmic release of the plasmid or oligonucleotide.
journal_name
Gene Therjournal_title
Gene therapyauthors
Hafez IM,Maurer N,Cullis PRdoi
10.1038/sj.gt.3301506keywords:
subject
Has Abstractpub_date
2001-08-01 00:00:00pages
1188-96issue
15eissn
0969-7128issn
1476-5462journal_volume
8pub_type
杂志文章相关文献
GENE THERAPY文献大全abstract：:Defensins are small cationic proteins that harbor broad-spectrum microbicidal activity against bacteria, fungi and viruses. This study examines the effects on pathogens of the epidermis engineered to express human beta-defensin 3 (HBD3) to combat bacterial infections. First, we examined the localization of HBD3 in the...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302472
更新日期：2005-05-01 00:00:00
abstract：:Inhibition of virus replication by means of RNA interference has been reported for several important human pathogens, including human immunodeficiency virus type 1 (HIV-1). RNA interference against these pathogens has been accomplished by introduction of virus-specific synthetic small interfering RNAs (siRNAs) or DNA ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302786
更新日期：2006-10-01 00:00:00
abstract：:Human adenovirus (Ad) vectors are extensively used as gene transfer vehicles. However, a serious obstacle for the use of these vectors in clinical applications is due to pre-existing immunity to human Ads affecting the efficacy of gene transfer. One of the approaches to circumvent host immune response could be the dev...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302146
更新日期：2004-01-01 00:00:00
abstract：:Relaxin-3 is a neuropeptide that is abundantly expressed by discrete brainstem neuron populations that broadly innervate forebrain areas rich in the relaxin-3 G-protein-coupled-receptor, RXFP3. Acute and subchronic central administration of synthetic relaxin-3 or an RXFP3-selective agonist peptide, R3/I5, increase fee...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2012.83
更新日期：2013-07-01 00:00:00
abstract：:Delivery of a normal copy of CFTR cDNA to airway epithelia may provide a novel treatment for cystic fibrosis lung disease. Unfortunately, current vectors are inefficient because of limited binding to the apical surface of airway epithelia. We recently reported that incorporation of adenovirus in a calcium phosphate co...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301020
更新日期：1999-11-01 00:00:00
abstract：:The insertion of suicide genes in donor T lymphocytes constitutes the basis of new approaches aiming at the treatment of the graft-versus-host disease (GVHD), a frequent complication in recipients of allogeneic haematopoietic grafts. In this study we investigated the impact that the ex vivo manipulation required for t...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302188
更新日期：2004-03-01 00:00:00
abstract：:We report on systemic delivery and long-term biological effects of apolipoprotein E (apoE) obtained by intramuscular (i.m.) plasmid DNA injection. ApoE plays an important role in lipoprotein catabolism and apoE knock-out mice develop severe hypercholesterolemia and diffuse atherosclerosis. We have injected apoE-defici...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301310
更新日期：2000-11-01 00:00:00
abstract：:Chimeric antigen receptors (CARs, immunoreceptors) are frequently used to redirect T cells with pre-defined specificity, in particular towards tumour cells for use in adoptive immunotherapy of malignant diseases. Specific targeting is mediated by an extracellularly located antibody-derived binding domain, which is joi...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.91
更新日期：2010-10-01 00:00:00
abstract：:Hepatic fibrosis is a common outcome of chronic liver diseases. In schistosomiasis, chronic parasite egg-induced granuloma formation can lead to fibrosis, which is immunologically characterized by the dominant Th2 response. Recently, it has been shown that gene therapy is an attractive approach for the treatment of he...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301524
更新日期：2001-09-01 00:00:00
abstract：:The development of efficient systems for in vivo gene transfer to the central nervous system (CNS) may provide a useful therapeutic strategy for the alleviation of several neurological disorders. In this study, we evaluated the feasibility of nonviral gene therapy to the CNS mediated by cationic liposomes. We present ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302516
更新日期：2005-08-01 00:00:00
abstract：:For patients with metastatic prostate cancer, the 5-year survival rate of 31% points to a need for novel therapies and improvement of existing modalities. We propose that p53 gene therapy and chemotherapy, when combined, will provide superior tumor cell killing for the treatment of prostate carcinoma. To this end, we ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-019-0071-x
更新日期：2020-02-01 00:00:00
abstract：:Regulated gene delivery systems are usually made of two elements: an inducible promoter and a transactivator. In order to optimize gene delivery and regulation, a single viral vector ensuring adequate stoichiometry of the two elements is required. However, efficient regulation is hampered by interferences between the ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301838
更新日期：2003-01-01 00:00:00
abstract：:We tested the longevity of gene expression provided by autonomously replicating vectors. The vectors contain segments of human genomic DNA that provide efficient replication initiation and sequences derived from Epstein-Barr virus that provide nuclear retention. In order to monitor gene expression, the vectors also ca...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1996-06-01 00:00:00
abstract：:Soluble receptors to vascular endothelial growth factor (VEGF) can inhibit its angiogenic effect. Since angiogenesis is involved in wound repair, we hypothesized that adenovirus-mediated gene transfer of a soluble form of VEGF receptor 2 (Flk-1) would attenuate wound healing in mice. C57Bl/6J and genetically diabetic ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302162
更新日期：2004-02-01 00:00:00
abstract：:Cancer therapies that target a single protein or pathway may be limited by their specificity, thus missing key players that control cellular proliferation and contributing to the failure of the treatment. We propose that approaches to cancer therapy that hit multiple targets would limit the chances of escape. To this ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-019-0096-1
更新日期：2020-02-01 00:00:00
abstract：:The pressing challenge for contemporary gene therapy is to deliver enough therapeutic genes to enough cancer cells in vivo. With the aim of improving viral distribution and tumor penetration, we explored the use of decorin to enhance viral spreading and tumor tissue penetration. We generated decorin-expressing replica...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.142
更新日期：2010-02-01 00:00:00
abstract：:RNA interference (RNAi) was reported to block hepatitis B virus (HBV) gene expression and replication in vitro and in vivo. However, it remains a technical challenge for RNAi-based therapy to achieve long-term and complete inhibition effects in chronic HBV infection, which presumably requires more extensive and unifor...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302846
更新日期：2007-01-01 00:00:00
abstract：:The E1 deleted adenoviral vectors are efficient at gene transfer to cells in culture or in animals. However, their use is limited because of an immune-mediated loss of transduced cells. This immune response is believed to result from low-level production of viral antigens from these vectors after gene transfer. The ea...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1995-06-01 00:00:00
abstract：:Intracardiac gene transfer and gene therapy have been investigated with different vector systems. Here we used adeno-associated virus (AAV) vectors to deliver either a reporter gene or a therapeutic gene into the heart of golden Syrian hamsters. The method of gene delivery was direct infusion of the AAV2 vectors into ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302078
更新日期：2003-10-01 00:00:00
abstract：:An amendment to this paper has been published and can be accessed via a link at the top of the paper. ...
journal_title：Gene therapy
pub_type： 已发布勘误
doi：10.1038/s41434-020-00186-x
更新日期：2020-08-01 00:00:00
abstract：:Somatic transgenesis can be used to confer endogenous production of proteins with therapeutic properties. One such product, recombinant soluble human CD4 (sCD4), has been shown to be an efficient inhibitor of human immunodeficiency virus 1 (HIV-1) in vitro, but its too short half-life in vivo has impaired long-term cl...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1995-05-01 00:00:00
abstract：:Recombinant adeno-associated virus (rAAV) vectors are attractive candidates for the treatment of inherited and acquired retinal disease. Although rAAV vectors are well characterized in rodent models, a prerequisite to their clinical application in human patients is the thorough evaluation of their efficacy and safety ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301990
更新日期：2003-08-01 00:00:00
abstract：:Newcastle disease virus (NDV) is an oncolytic paramyxovirus with a nonsegmented single-stranded RNA genome. In this report, a recombinant oncolytic NDV was passaged in human tumor xenografts and reisolated and characterized after two rounds of bioselection. Several isolates could be recovered that differed from the pa...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2012.13
更新日期：2013-01-01 00:00:00
abstract：:Green fluorescent protein (GFP) is a widely used intracellular reporter molecule to assess gene transfer and expression. A potential use for GFP is as a co-expressed marker, to select and enrich gene-modified cells by flow cytometry. Processed peptides derived from GFP and presented by the major histocompatibility com...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300951
更新日期：1999-07-01 00:00:00
abstract：:Excessive activated T-cell proliferation was observed in vivo in one patient after an anti-CD19-chimeric antigen receptor (CAR) T-cell infusion. The patient, who had chemotherapy refractory and CD19+ diffuse large B-cell lymphoma (DLBCL), received an anti-CD19 CAR T-cell infusion following conditioning chemotherapy (f...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-017-0001-8
更新日期：2018-06-01 00:00:00
abstract：:In utero somatic gene transfer may be a useful therapeutic strategy for a variety of inherited disorders. In the present study, we demonstrate transgene expression in the airways of fetal lamb lungs, 2-3 weeks after injection of Moloney murine leukemia retrovirus based vectors containing cDNA for beta-galactosidase (l...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1995-07-01 00:00:00
abstract：:We have developed a retroviral vector coexpressing the multidrug-resistance 1 (MDR1) cDNA for inducing cancer drug resistance and the truncated version of the low-affinity nerve growth factor receptor (DeltaLNGFR) for cell-surface marking of transduced cells. The vector is based on the FMEV backbone which mediates hig...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300942
更新日期：1999-07-01 00:00:00
abstract：:In muscle, mutant genes can be targeted and corrected directly by intramuscular (i.m.) injection of corrective DNA, or by ex vivo delivery of DNA to myogenic cells, followed by cell transplantation. Short fragment homologous replacement (SFHR) has been used to repair the exon 23 nonsense transition at the Xp21.1 dys l...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301737
更新日期：2002-06-01 00:00:00
abstract：:Schwann cells (SCs) in an injured peripheral nerve form pathways for regenerating axons. Although these cells initially support regeneration, SCs lose their pro-regenerative properties following a prolonged period of denervation. Gene transfer to SC can enhance their therapeutic potential. In this article, we compared...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2015.47
更新日期：2015-10-01 00:00:00
abstract：:Retroviral vectors are being used increasingly in clinical gene therapy protocols but low transduction frequencies are presenting a significant obstacle to progress. In this paper we report a simple method to enhance the efficiency of ex vivo retroviral gene transfer. Calcium chloride is added to the vector stock and ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1995-09-01 00:00:00
